PatentsUSA
Moderna Settlement Caps Covid-19 Vaccine Patent Liability at $2.25 Billion, Sets Stage for Federal Circuit Appeal on Government-Contractor Immunity
Moderna Inc. has reached a landmark settlement with Arbutus Biopharma and Genevant Sciences over patent infringement claims related to lipid-nanoparticle technology used in its Covid-19 vaccine. The agreement limits Moderna’s total liability to $2.25 billion and includes a planned appeal to the Federal Circuit on the…
Thursday, March 5, 2026